NCT05501132

Brief Summary

This is a randomized, double-blind, parallel-group, sham-controlled trial that aims to investigate the effectiveness of transcranial direct current stimulation (TDCS) on improving symptoms, quality of life, depression, and cognitive functions in 39 patients with obsessive-compulsive disorder (OCD) that are randomized in 3 experimental groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Aug 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2020

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2021

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 25, 2022

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 12, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 15, 2022

Completed
Last Updated

March 17, 2026

Status Verified

March 1, 2026

Enrollment Period

10 months

First QC Date

August 12, 2022

Last Update Submit

March 15, 2026

Conditions

Outcome Measures

Primary Outcomes (5)

  • Yale-Brown Obsessive-Compulsive (Y-BOCS) rating scale

    Score in the Yale-Brown Obsessive-Compulsive (Y-BOCS). Total scores on the measure range from 0 to 40, with a score of 0-7 indicating subclinical symptoms, 8-15 mild symptoms, 16-23 moderate symptoms, 24-31 severe symptoms and 32-40 extreme symptoms.

    up to 1 month after the intervention

  • Beck Anxiety Questionnaire (BAI)

    Score in the Beck Anxiety Questionnaire (BAI). The BAI scores are classified as minimal anxiety (0 to 7), mild anxiety (8 to 15), moderate anxiety (16 to 25), and severe anxiety (30 to 63).

    up to 1 month after the intervention

  • Response inhibition task 1

    Performance in the response inhibition tasks (Flanker test)

    up to 1 month after the intervention

  • Working memory task

    Performance in the working memory task as an executive function task

    up to 1 month after the intervention

  • Response inhibition task 2

    Performance in the response inhibition tasks (Go/No-Go task)

    up to 1 month after the intervention

Secondary Outcomes (4)

  • Beck Depression Questionnaire (BDI-II)

    up to 1 month after the intervention

  • Quality of Life Questionnaire (WHOQUL)

    up to 1 month after the intervention

  • electroencephalogram (EEG) oscillatory power

    up to 1 month after the intervention

  • electroencephalogram (EEG) functional connectivity

    up to 1 month after the intervention

Study Arms (3)

tDCS group 1

EXPERIMENTAL

In the first experimental group, the TDCS intervention protocol consists of 10 sessions of 20 minutes of 1 mA electrical stimulation on 5 consecutive days with two sessions per day.

Device: transcranial direct current stimulation

tDCS group 2

EXPERIMENTAL

In the second experimental group, the TDCS intervention protocol consists of 10 sessions of 20 minutes of 2 mA electrical stimulation on 5 consecutive days with two sessions per day.

Device: transcranial direct current stimulation

Control group

PLACEBO COMPARATOR

In the placebo group, the TDCS intervention protocol consists of 10 sessions of 20 minutes of sham electrical stimulation on 5 consecutive days with two sessions per day.

Device: transcranial direct current stimulation

Interventions

Patients will receive 10 sessions of 20 minutes of either 1 mA, 2 mA or sham electrical stimulation on 5 consecutive days

Also known as: tDCS
Control grouptDCS group 1tDCS group 2

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnosis of Obsessive-compulsive Disorder by a psychiatrist and DSM-5-based behavioral checklist
  • being 18-50 years old
  • providing written informed consent
  • If female, negative urine pregnancy test
  • stable medication regime especially the classical neuroleptics and all CNS-activating medications, if taken, 4-6 weeks before the experiment and during the experiment

You may not qualify if:

  • smoker
  • pregnancy
  • alcohol or substance dependence
  • history of seizure
  • history of neurological disorder
  • history of head injury
  • presence of ferromagnetic objects in the body that are contraindicated for brain stimulation of the head (pacemakers or other implanted electrical devices, brain stimulators, some types of dental implants, aneurysm clips, metallic prostheses, permanent eyeliner, implanted delivery pump, or shrapnel fragments) or fear of enclosed spaces.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ardabil University of Medical Sciences

Ardabil, Iran

Location

Related Publications (1)

  • Alizadehgoradel J, Molaei B, Barzegar Jalali K, Pouresmali A, Sharifi K, Hallajian AH, Nejati V, Glinski B, Vicario CM, Nitsche MA, Salehinejad MA. Targeting the prefrontal-supplementary motor network in obsessive-compulsive disorder with intensified electrical stimulation in two dosages: a randomized, controlled trial. Transl Psychiatry. 2024 Feb 5;14(1):78. doi: 10.1038/s41398-024-02736-y.

Related Links

MeSH Terms

Interventions

Transcranial Direct Current Stimulation

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 12, 2022

First Posted

August 15, 2022

Study Start

August 1, 2020

Primary Completion

June 1, 2021

Study Completion

February 25, 2022

Last Updated

March 17, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations